Walleye Trading LLC Avadel Pharmaceuticals PLC Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$3.34 - $7.7 $89,926 - $207,314	-26,924 Reduced 86.63%	4,154 $31,000
Q3 2019 Nov 14, 2019	BUY	$1.92 - $4.47 $59,669 - $138,918	31,078 New	31,078 $129,000
Q4 2018 Feb 14, 2019	SELL	$1.74 - $4.66 $5,220 - $13,980	-3,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$4.08 - $7.14 $12,240 - $21,420	3,000 New	3,000 $13,000
Q4 2017 Feb 14, 2018	SELL	$8.03 - $11.25 $256,959 - $360,000	-32,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.35 - $10.5 $25,885 - $32,550	3,100 Added 10.73%	32,000 $336,000
Q2 2017 Aug 14, 2017	BUY	N/A	28,900	28,900 $319,000

1.07M

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.